Compare ENTA & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | ABAT |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.3M | 522.9M |
| IPO Year | 2013 | N/A |
| Metric | ENTA | ABAT |
|---|---|---|
| Price | $15.87 | $3.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.40 | N/A |
| AVG Volume (30 Days) | 370.9K | ★ 5.6M |
| Earning Date | 02-09-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,324,000.00 | $5,025,853.00 |
| Revenue This Year | $0.99 | $145.40 |
| Revenue Next Year | $0.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 821.40 |
| 52 Week Low | $4.09 | $0.86 |
| 52 Week High | $17.15 | $11.49 |
| Indicator | ENTA | ABAT |
|---|---|---|
| Relative Strength Index (RSI) | 60.04 | 37.77 |
| Support Level | $14.07 | $3.61 |
| Resistance Level | $17.15 | $4.43 |
| Average True Range (ATR) | 0.95 | 0.35 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 56.71 | 2.98 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.